XML 378 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair values of financial instruments not carried at fair value
12 Months Ended
Dec. 31, 2024
Fair Value Measurement [Abstract]  
Fair values of financial instruments not carried at fair value 12Fair values of financial instruments carried at fair value
Control framework
Fair values are subject to a control framework designed to ensure that they are either determined or validated by a function independent of the
risk taker.
Where fair values are determined by reference to externally quoted prices or observable pricing inputs to models, independent price
determination or validation is used. For inactive markets, HSBC sources alternative market information, with greater weight given to
information that is considered to be more relevant and reliable. Examples of the factors considered are price observability, instrument
comparability, consistency of data sources, underlying data accuracy and timing of prices.
For fair values determined using valuation models, the control framework includes development or validation by independent support functions
of the model logic, inputs, model outputs and adjustments. Valuation models are subject to a process of due diligence before becoming
operational and are calibrated against external market data on an ongoing basis.
Changes in fair value are generally subject to a profit and loss analysis process and are disaggregated into high-level categories including
portfolio changes, market movements and other fair value adjustments.
The majority of financial instruments measured at fair value are in GBM. GBM’s fair value governance structure comprises its Finance function,
Valuation Committees and a Valuation Committee Review Group. Finance is responsible for establishing procedures governing valuation and
ensuring fair values are in compliance with accounting standards. The fair values are reviewed by the Valuation Committees, which consist of
independent support functions. These committees are overseen by the Valuation Committee Review Group, which considers all material
subjective valuations.
Financial liabilities measured at fair value
In certain circumstances, HSBC records its own debt in issue at fair value, based on quoted prices in an active market for the specific
instrument. When quoted market prices are unavailable, the own debt in issue is valued using valuation techniques, the inputs for which are
either based on quoted prices in an inactive market for the instrument or are estimated by comparison with quoted prices in an active market
for similar instruments. In both cases, the fair value includes the effect of applying the credit spread that is appropriate to HSBC’s liabilities. The
change in fair value of issued debt securities attributable to the Group’s own credit spread is computed as follows: for each security at each
reporting date, an externally verifiable price is obtained or a price is derived using credit spreads for similar securities for the same issuer. Then,
using discounted cash flow, each security is valued using an appropriate market discount curve. The difference in the valuations is attributable
to the Group’s own credit spread. This methodology is applied consistently across all securities.
Structured notes issued and certain other hybrid instruments are reported as financial liabilities designated at fair value. The credit spread
applied to these instruments is derived from the spreads at which HSBC issues structured notes.
Gains and losses arising from changes in the credit spread of liabilities issued by HSBC, recorded in other comprehensive income, reverse over
the contractual life of the debt, provided that the debt is not repaid at a premium or a discount.
Fair value hierarchy
Fair values of financial assets and liabilities are determined according to the following hierarchy:
Level 1 – valuation technique using quoted market price. These are financial instruments with quoted prices for identical instruments in
active markets that HSBC can access at the measurement date.
Level 2 – valuation technique using observable inputs. These are financial instruments with quoted prices for similar instruments in active
markets or quoted prices for identical or similar instruments in inactive markets and financial instruments valued using models where all
significant inputs are observable.
Level 3 – valuation technique with significant unobservable inputs. These are financial instruments valued using valuation techniques where
one or more significant inputs are unobservable.
Financial instruments carried at fair value and bases of valuation
2024
2023
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
$m
$m
$m
$m
$m
$m
$m
$m
Recurring fair value measurements at 31 Dec
Assets
Trading assets
236,593
71,574
6,675
314,842
202,020
82,833
4,306
289,159
Financial assets designated and otherwise mandatorily
measured at fair value through profit or loss
39,331
56,694
19,744
115,769
27,030
63,825
19,788
110,643
Derivatives
1,859
264,629
2,149
268,637
931
226,714
2,069
229,714
Financial investments
258,371
78,088
2,734
339,193
215,228
76,591
2,618
294,437
Liabilities
Trading liabilities
42,038
23,160
784
65,982
53,354
19,318
478
73,150
Financial liabilities designated at fair value
2,152
127,458
9,117
138,727
1,266
129,232
10,928
141,426
Derivatives
1,088
260,518
2,842
264,448
1,918
230,285
2,569
234,772
The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale
in accordance with IFRS 5. For further details, see Note 23.
Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale
2024
2023
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
$m
$m
$m
$m
$m
$m
$m
$m
Recurring fair value measurements at 31 Dec
Assets
Trading assets
2,403
61
2,465
Financial assets designated and otherwise mandatorily
measured at fair value through profit or loss
2,967
9,018
2,575
14,560
15
49
64
Derivatives
36
36
528
528
Financial investments
2,651
5,345
504
8,500
9,357
28
9,385
Liabilities
Trading liabilities
1,352
64
1,417
Financial liabilities designated at fair value
130
130
2,370
2,370
Derivatives
19
19
615
615
Transfers between Level 1 and Level 2 fair values
Assets
Liabilities
Financial
investments
Trading
assets
Designated and otherwise
mandatorily measured
at fair value
Derivatives
Trading
liabilities
Designated
at fair
value
Derivatives
$m
$m
$m
$m
$m
$m
$m
At 31 Dec 2024
Transfers from Level 1 to Level 2
13,511
9,246
1,540
191
Transfers from Level 2 to Level 1
10,752
6,060
3,042
159
At 31 Dec 2023
Transfers from Level 1 to Level 2
13,200
8,066
1,709
54
Transfers from Level 2 to Level 1
9,975
5,758
2,477
309
Transfers between levels of the fair value hierarchy are deemed to occur at the end of each quarterly reporting period. Transfers are primarily
attributable to changes in price transparency and in the assessment of observability.
Fair value adjustments
Fair value adjustments take into consideration additional factors not incorporated within the primary product valuation model that would
otherwise be considered by a market participant. Adjustments are calculated using model infrastructure including those within primary valuation
systems. We classify fair value adjustments as either ‘risk-related’ or ‘model-related’. The majority of these adjustments relate to MSS.
Movements in the amount of fair value adjustments do not necessarily translate in equivalent movements of profits or losses within the
income statement, as these movements can be compensated by other related profits or loss effects. For example, as models are enhanced,
fair value adjustments may no longer be required. Similarly, fair value adjustments will decrease when the related positions are unwound, but
this may not result in profit or loss.
Fair value adjustments
2024
2023
GBM
Corporate
Centre
GBM
Corporate
Centre
$m
$m
$m
$m
Type of adjustment
Risk-related
634
35
692
41
–  bid-offer
366
2
414
–  uncertainty
98
3
75
3
–  credit valuation adjustment
126
27
164
35
–  debit valuation adjustment
(24)
(54)
–  funding fair value adjustment
68
3
93
3
Model-related
50
63
–  model limitation
50
63
Inception profit (Day 1 P&L reserves)
92
86
At 31 Dec
776
35
841
41
The net reduction in fair value adjustments was predominantly driven by changes to exposure, and tightening of credit and liquidity market
spreads.
Bid-offer
IFRS 13 ‘Fair Value Measurement’ requires the use of the price within the bid-offer spread that is most representative of fair value. Valuation
models will typically generate mid-market values. The bid-offer adjustment reflects the extent to which bid-offer costs would be incurred if
substantially all residual net portfolio market risks were closed using available hedging instruments or by disposing of or unwinding the position.
Uncertainty
Certain model inputs may be less readily determinable from market data and/or the choice of model itself may be more subjective. In these
circumstances, an adjustment may be necessary to reflect the likelihood that market participants would adopt more conservative values for
uncertain parameters and/or model assumptions than those used in HSBC’s valuation model.
Credit and debit valuation adjustments
The credit valuation adjustment (‘CVA’) is an adjustment to the valuation of over-the-counter (‘OTC’) derivative contracts to reflect the possibility
that the counterparty may default and that HSBC may not receive the full market value of the transactions.
The debit valuation adjustment (‘DVA’) is an adjustment to the valuation of OTC derivative contracts to reflect the possibility that HSBC may
default, and that it may not pay the full market value of the transactions. The DVA considers the overlap with the funding fair value adjustment.
HSBC calculates a separate CVA and DVA for each legal entity, and for each counterparty to which the entity has exposure. With the exception
of central clearing parties, all third-party counterparties are included in the CVA and DVA calculations, and these adjustments are not netted
across Group entities.
HSBC calculates the CVA by applying the probability of default (‘PD’) of the counterparty, conditional on the non-default of HSBC, to HSBC’s
expected positive exposure to the counterparty and multiplying the result by the loss expected in the event of default. Conversely, HSBC calculates
the DVA by applying the PD of HSBC, conditional on the non-default of the counterparty, to the expected positive exposure of the counterparty to
HSBC and multiplying the result by the loss expected in the event of default. Both calculations are performed over the life of the potential exposure.
For most products HSBC uses a simulation methodology, which incorporates a range of potential exposures over the life of the portfolio, to
calculate the expected positive exposure to a counterparty. The simulation methodology includes credit mitigants, such as counterparty netting
agreements and collateral agreements with the counterparty.
The methodologies do not, in general, account for ‘wrong-way risk’. Wrong-way risk is an adverse correlation between the counterparty’s probability of
default and the mark-to-market value of the underlying transaction. The risk can either be general, perhaps related to the currency of the issuer country,
or specific to the transaction concerned. When there is significant wrong-way risk, a trade-specific approach is applied to reflect this risk in the valuation.
Funding fair value adjustment
The funding fair value adjustment (‘FFVA’) is calculated by applying future market funding spreads to the expected future funding exposure of
any uncollateralised component of the OTC derivative portfolio. The expected future funding exposure is calculated by a simulation
methodology, where available, and is adjusted for events that may terminate the exposure, such as the default of HSBC or the counterparty.
Model limitation
Models used for portfolio valuation purposes may be based upon a simplified set of assumptions that do not capture all current and future
material market characteristics. In these circumstances, model limitation adjustments are adopted.
Inception profit (Day 1 P&L reserves)
Inception profit adjustments are adopted when the fair value estimated by a valuation model is based on one or more significant unobservable
inputs. The accounting for inception profit adjustments is discussed in Note 1.
Fair value valuation bases
Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3
Assets
Liabilities
Financial
investments
Trading
assets
Designated and
otherwise mandatorily
measured at fair value
through profit or loss
Derivatives
Total
Trading
liabilities
Designated
at fair
value
Derivatives
Total
$m
$m
$m
$m
$m
$m
$m
$m
$m
Private equity including
strategic investments
552
1
17,705
18,258
1
1
Asset-backed securities
182
198
380
Structured notes
3
3
9,113
9,113
Other derivatives
2,149
2,149
2,842
2,842
Other portfolios
2,000
6,476
2,036
10,512
784
3
787
At 31 Dec 2024
2,734
6,675
19,744
2,149
31,302
784
9,117
2,842
12,743
Private equity including
strategic investments
507
7
17,640
18,154
1
1
Asset-backed securities
309
128
8
445
Structured notes
3
3
10,331
10,331
Other derivatives
2,069
2,069
2,569
2,569
Other portfolios
1,802
4,171
2,137
8,110
478
596
1,074
At 31 Dec 2023
2,618
4,306
19,788
2,069
28,781
478
10,928
2,569
13,975
Level 3 instruments are present in both ongoing and legacy businesses. Loans held for securitisation, derivatives with monolines, certain ‘other
derivatives’ and predominantly all Level 3 asset-backed securities are legacy positions. HSBC has the capability to hold these positions.
Private equity including strategic investments
The fair value of a private equity investment (including strategic investments) is estimated on the basis of an analysis of the investee’s financial
position and results, risk profile, prospects and other factors; by reference to market valuations for similar entities quoted in an active market;
the price at which similar companies have changed ownership; or from published net asset values (‘NAV’) received. If necessary, adjustments
are made to the NAV of funds to obtain the best estimate of fair value.
Asset-backed securities
While quoted market prices are generally used to determine the fair value of the asset-backed securities (‘ABSs’), valuation models are used to
substantiate the reliability of the limited market data available and to identify whether any adjustments to quoted market prices are required.
For certain ABSs, such as residential mortgage-backed securities, the valuation uses an industry standard model with assumptions relating to
prepayment speeds, default rates and loss severity based on collateral type, and performance, as appropriate. The valuations output is
benchmarked for consistency against observable data for securities of a similar nature.
Structured notes
The fair value of Level 3 structured notes is derived from the fair value of the underlying debt security, and the fair value of the embedded derivative is
determined as described in the paragraph below on derivatives. These structured notes comprise principally equity-linked notes issued by HSBC,
which provide the counterparty with a return linked to the performance of equity securities and other portfolios. Examples of the unobservable
parameters include long-dated equity volatilities and correlations between equity prices, and interest and foreign exchange rates.
Derivatives
OTC derivative valuation models calculate the present value of expected future cash flows, based upon ‘no arbitrage’ principles. For many
vanilla derivative products, the modelling approaches used are standard across the industry. For more complex derivative products, there may
be some differences in market practice. Inputs to valuation models are determined from observable market data wherever possible, including
prices available from exchanges, dealers, brokers or providers of consensus pricing. Certain inputs may not be observable in the market
directly, but can be determined from observable prices via model calibration procedures or estimated from historical data or other sources.
Reconciliation of fair value measurements in Level 3 of the fair value hierarchy
Movement in Level 3 financial instruments
Assets
Liabilities
Financial
investments
Trading
assets
Designated and
otherwise
mandatorily
measured at fair
value through
profit or loss
Derivatives
Trading
liabilities
Designated
at fair
value
Derivatives
$m
$m
$m
$m
$m
$m
$m
At 1 Jan 2024
2,618
4,306
19,788
2,069
478
10,928
2,569
Total gains/(losses) recognised in profit or loss
(9)
280
896
1,037
18
496
1,268
–  net income/(losses) from financial instruments
held for trading or managed on a fair value basis
280
1,037
18
496
1,268
–  net income from assets and liabilities of insurance
businesses, including related derivatives,
measured at fair value through profit or loss
684
–  changes in fair value of other financial instruments
mandatorily measured at fair value through profit
or loss
212
–  gains less losses from financial investments at fair
value through other comprehensive income
(9)
Total gains/(losses) recognised in other
comprehensive income (‘OCI’)1
(78)
(115)
(39)
(36)
(18)
(45)
(53)
–  financial investments: fair value gains/(losses)
18
33
–  exchange differences
(96)
(115)
(39)
(36)
(18)
(78)
(53)
Purchases
1,670
4,170
6,261
924
New issuances
6,521
Sales
(97)
(1,477)
(649)
(295)
Settlements2
(1,011)
(967)
(6,476)
(897)
(307)
(4,750)
(568)
Transfers out3
(438)
(429)
(278)
(777)
(29)
(6,048)
(1,346)
Transfers in3
79
907
241
753
13
2,015
972
At 31 Dec 2024
2,734
6,675
19,744
2,149
784
9,117
2,842
Unrealised gains/(losses) recognised in profit or loss
relating to assets and liabilities held at 31 Dec 2024
(150)
11
(1,377)
(6)
(94)
(1,343)
–  net income/(losses) from financial instruments
held for trading or managed on a fair value basis
(150)
(1,377)
(6)
(1,343)
–  changes in fair value of other financial instruments
mandatorily measured at fair value through profit
or loss
11
(94)
At 1 Jan 2023
2,961
4,817
17,407
1,964
474
10,432
2,920
Total gains/(losses) recognised in profit or loss
(44)
266
921
692
75
97
910
–  net income/(losses) from financial instruments
held for trading or managed on a fair value basis
266
692
75
97
910
–  net income from assets and liabilities of insurance
businesses, including related derivatives,
measured at fair value through profit or loss
–  changes in fair value of other financial instruments
mandatorily measured at fair value through profit
or loss
921
–  gains less losses from financial investments at fair
value through other comprehensive income
(44)
Total gains/(losses) recognised in other
comprehensive income (‘OCI’)1
28
108
87
81
24
523
111
–  financial investments: fair value gains/(losses)
(44)
335
–  exchange differences
72
108
87
81
24
188
111
Purchases
353
2,276
3,555
291
New issuances
2
2
5,389
Sales
(290)
(2,478)
(658)
(320)
(2)
Settlements
(352)
(872)
(1,886)
(1,018)
(74)
(3,258)
(1,565)
Transfers out
(662)
(922)
(156)
(240)
(45)
(2,881)
(358)
Transfers in
624
1,109
518
590
51
628
551
At 31 Dec 2023
2,618
4,306
19,788
2,069
478
10,928
2,569
Unrealised gains/(losses) recognised in profit or loss
relating to assets and liabilities held at 31 Dec 2023
(152)
82
737
(433)
(903)
–  net income/(losses) from financial instruments
held for trading or managed on a fair value basis
(152)
737
(903)
–  changes in fair value of other financial instruments
mandatorily measured at fair value through profit
or loss
82
(433)
1Included in ‘financial investments: fair value gains/(losses)’ in the current year and ‘exchange differences’ in the consolidated statement of comprehensive income.
2Includes $3.1bn decrease from classification of the assets of our French Life Insurance business as assets held for sale.
3Includes $4.4bn of transfers out and $1.5bn of transfers in relating to enhancement of observability assessments on equity structured notes.
Transfers between levels of the fair value hierarchy are deemed to occur at the end of each quarterly reporting period. Transfers are primarily
attributable to changes in price transparency and in the assessment of observability.
Effect of changes in significant unobservable assumptions to reasonably
possible alternatives
Sensitivity of fair values to reasonably possible alternative assumptions
2024
2023
Reflected in profit or loss
Reflected in OCI
Reflected in profit or loss
Reflected in OCI
Favourable
changes
Un-
favourable
changes
Favourable
changes
Un-
favourable
changes
Favourable
changes
Un-
favourable
changes
Favourable
changes
Un-
favourable
changes
$m
$m
$m
$m
$m
$m
$m
$m
Derivatives, trading assets and trading
liabilities1
481
(313)
492
(531)
Financial assets and liabilities designated
and otherwise mandatorily measured at
fair value through profit or loss
1,434
(1,141)
1,092
(1,100)
Financial investments
21
(21)
47
(50)
13
(12)
61
(66)
At 31 Dec
1,936
(1,475)
47
(50)
1,597
(1,643)
61
(66)
1‘Derivatives, trading assets and trading liabilities’ are presented as one category to reflect the manner in which these instruments are risk-managed.The sensitivity analysis for certain private equity positions has been enhanced in order to reduce dependency on historical observations and
focus on current valuation uncertainty, resulting in some increases in favourable sensitivities.
The sensitivity analysis aims to measure a range of fair values consistent with the application of a 95% confidence interval. Methodologies take
account of the nature of the valuation technique employed, as well as the availability and reliability of observable proxy and historical data.
When the fair value of a financial instrument is affected by more than one unobservable assumption, the above table reflects the most
favourable or the most unfavourable change from varying the assumptions individually.
Key unobservable inputs to Level 3 financial instruments
The following table lists key unobservable inputs to Level 3 financial instruments and provides the range of those inputs at 31 December 2024.
Quantitative information about significant unobservable inputs in Level 3 valuations
Fair value
2024
2023
Assets
Liabilities
Key valuation
techniques
Key unobservable
inputs
Full range
of inputs
Full range
of inputs
$m
$m
Lower
Higher
Lower
Higher
Private equity including strategic
investments2
18,258
1
Price – Net asset value
Current Value/Cost
0
291
See footnote 2
Asset-backed securities
380
–  collateralised loan/debt obligation
100
Market proxy
Price
0
97
0
94
–  other ABSs
280
Market proxy
Price
0
248
0
220
Structured notes
3
9,113
–  equity-linked notes
3
5,739
Model – Option model
Equity volatility
6%
70%
6%
154%
Model – Option model
Equity correlation
15%
100%
34%
100%
–  Foreign exchange-linked notes
1,833
Model – Option model
Foreign exchange
volatility
3%
35%
1%
34%
–  other structured notes
1,541
Derivatives
2,149
2,842
 
 
–  interest rate derivatives
1,102
1,066
 
 
    securitisation swaps
196
186
Model – Discounted cash flow
Prepayment rate
5%
10%
5%
10%
    long-dated swaptions
71
76
Model – Option model
Interest rate
volatility
9%
30%
11%
37%
    other interest rate derivatives
835
804
–  Foreign exchange derivatives
202
212
    Foreign exchange options
154
174
Model – Option model
Foreign exchange
volatility
1%
26%
1%
31%
    other foreign exchange derivatives
48
38
–  equity derivatives
460
638
    long-dated single stock options
145
166
Model – Option model
Equity volatility
6%
118%
6%
110%
    other equity derivatives
315
472
–  credit derivatives
376
922
    total return swaps
349
847
Market proxy
Price
0
104
0
104
    other credit derivatives
27
75
–  other derivatives
9
4
Other portfolios
10,512
787
–  repurchase agreements
1,739
742
Model – Discounted cash flow
Interest rate curve
0%
26%
3%
8%
–  bonds
4,300
27
Market proxy
Price
0
140
0
101
–  other1
4,473
18
At 31 Dec 2024
31,302
12,743
1‘Other’ includes a range of asset holdings including loans and deposits, syndicated loans and infrastructure debt.
2‘Private equity including strategic investments’ includes private equity, private credit and private equity fund, primarily held as part of our Insurance business and
for strategic investments. The analysis for private equity positions has been enhanced with the range of key unobservable inputs now quoted.
The range of values above shows the highest and lowest unobservable inputs that have been used to value significant Level 3 exposures and
reflects the diversity of the underlying financial instruments in scope and subsequent differentiation in pricing.
Private equity including strategic investments
The ‘private equity’ holdings include private equity investments and private equity funds held as limited partners. The key unobservable input is
the current value of the underlying positions, determined using valuation techniques in line with the International Capital Valuation Guidelines.
The inputs represented are an appropriate range of inputs normalised across different exposure types.
Prepayment rates
Prepayment rates are a measure of the anticipated future speed at which a loan portfolio will be repaid in advance of the due date. They vary
according to the nature of the loan portfolio and expectations of future market conditions, and may be estimated using a variety of evidence,
such as prepayment rates implied from proxy observable security prices, current or historical prepayment rates and macroeconomic modelling.
Market proxy
Market proxy pricing may be used for an instrument when specific market pricing is not available but there is evidence from instruments with
common characteristics. In some cases it might be possible to identify a specific proxy, but more generally evidence across a wider range of
instruments will be used to understand the factors that influence current market pricing and the manner of that influence.
Volatility
Volatility is a measure of the anticipated future variability of a market price. It varies by underlying reference market price, and by strike and
maturity of the option. Certain volatilities, typically those of a longer-dated nature, are unobservable and are estimated from observable data.
The range of unobservable volatilities reflects the wide variation in volatility inputs by reference market price.
Correlation
Correlation is a measure of the inter-relationship between two market variables and is expressed as a number between minus one and one. It
is used to value more complex instruments where the payout is dependent upon more than one market variable. There is a wide range of
instruments for which correlation is an input, and consequently a wide range of both same-asset correlations and cross-asset correlations is
used. In general, the range of same-asset correlations will be narrower than the range of cross-asset correlations.
Unobservable correlations may be estimated based upon a range of evidence, including consensus pricing services, HSBC trade prices, proxy
correlations and examination of historical price relationships. The range of unobservable correlations quoted in the table reflects the wide
variation in correlation inputs by market variable pair.
Credit spread
Credit spread is the premium over a benchmark interest rate required by the market to accept lower credit quality. In a discounted cash flow
model, the credit spread increases the discount factors applied to future cash flows, thereby reducing the value of an asset. Credit spreads may
be implied from market prices and may not be observable in more illiquid markets.
Inter-relationships between key unobservable inputs
Key unobservable inputs to Level 3 financial instruments may not be independent of each other. As described above, market variables may be
correlated. This correlation typically reflects the manner in which different markets tend to react to macroeconomic or other events.
Furthermore, the effect of changing market variables on the HSBC portfolio will depend on HSBC’s net risk position in respect of each variable.
HSBC Holdings
Basis of valuing HSBC Holdings’ financial assets and liabilities measured at fair value
2024
2023
Level 1
Level 2
Total
Level 1
Level 2
Total
$m
$m
$m
$m
$m
$m
Recurring fair value measurement
Assets at 31 Dec
Trading assets
709
709
Financial assets with HSBC undertakings designated and
otherwise mandatorily measured at fair value
61,286
61,286
59,879
59,879
Derivatives
3,054
3,054
3,344
3,344
Liabilities at 31 Dec
Financial liabilities designated at fair value
41,582
41,582
43,638
43,638
Derivatives
5,340
5,340
6,090
6,090
13
Fair values of financial instruments not carried at fair value
Fair values of financial instruments not carried at fair value and bases of valuation
Fair value
Carrying
amount
Quoted market
price Level 1
Observable
inputs Level 2
Significant
unobservable
inputs Level 3
Total
$m
$m
$m
$m
$m
At 31 Dec 2024
Assets
Loans and advances to banks
102,039
101,007
1,048
102,055
Loans and advances to customers1
930,658
11,435
906,208
917,643
Reverse repurchase agreements – non-trading
252,549
252,598
252,598
Financial investments – at amortised cost
153,973
120,843
29,493
724
151,060
Liabilities
Deposits by banks
73,997
74,025
74,025
Customer accounts
1,654,955
1,655,151
1,655,151
Repurchase agreements – non-trading
180,880
180,873
180,873
Debt securities in issue
105,785
105,689
954
106,643
Subordinated liabilities
25,958
28,262
28,262
At 31 Dec 2023
Assets
Loans and advances to banks
112,902
2
111,263
1,479
112,744
Loans and advances to customers
938,535
13,258
911,124
924,382
Reverse repurchase agreements – non-trading
252,217
252,243
252,243
Financial investments – at amortised cost
148,326
115,383
30,765
440
146,588
Liabilities
Deposits by banks
73,163
73,176
73,176
Customer accounts
1,611,647
1,611,795
1,611,795
Repurchase agreements – non-trading
172,100
172,081
172,081
Debt securities in issue
93,917
93,196
706
93,902
Subordinated liabilities
24,954
27,151
27,151
1Includes retained portfolio of French home and other loans following the sale of retail banking operations in France, with carrying amount of $6.9bn (2023:
$7.9bn). We reclassified the portfolio to a hold-to-collect-and-sell business model from 1 January 2025 and will measure it prospectively from the first quarter of
2025 at fair value through other comprehensive income. We expect to recognise an estimated $1bn fair value pre-tax loss in other comprehensive income on
the remeasurement of these financial instruments. The valuation of this portfolio of loans may be substantially different in the event of a sale due to entity and
deal-specific factors, including funding costs and the value of customer relationships (refer Note 23 for details).
Fair values of financial instruments not carried at fair value and bases of valuation – assets and disposal groups held for sale
Fair value
Carrying
amount
Quoted market
price Level 1
Observable
inputs Level 2
Significant
unobservable
inputs Level 3
Total
$m
$m
$m
$m
$m
At 31 Dec 2024
Assets
Loans and advances to banks
144
144
144
Loans and advances to customers
977
11
966
977
Reverse repurchase agreements – non-trading
Financial investments – at amortised cost
Liabilities
Deposits by banks
Customer accounts
5,399
5,399
5,399
Repurchase agreements – non-trading
Debt securities in issue
Subordinated liabilities
At 31 Dec 2023
Assets
Loans and advances to banks
10,487
10,487
10,487
Loans and advances to customers
73,376
90
72,200
72,290
Reverse repurchase agreements – non-trading
2,723
2,723
2,723
Financial investments – at amortised cost
7,624
7,530
5
7,535
Liabilities
Deposits by banks
78
78
78
Customer accounts
85,950
86,475
86,475
Repurchase agreements – non-trading
2,768
2,768
2,768
Debt securities in issue
9,084
8,820
8,820
Subordinated liabilities
8
7
7
Other financial instruments not carried at fair value are typically short term in nature and reprice to current market rates frequently. Accordingly,
their carrying amount is a reasonable approximation of fair value. They include cash and balances at central banks, Hong Kong Government
certificates of indebtedness and Hong Kong currency notes in circulation, all of which are measured at amortised cost.
Valuation
Fair value is an estimate of the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. This may be different from the theoretical economic value attributed from an instrument’s cash
flows over its expected future life. Our valuation methodologies and assumptions in determining fair values for which no observable market
prices are available may differ from those of other companies.
Loans and advances to banks and customers
To determine the fair value of loans and advances to banks and customers, loans are segregated into portfolios of similar characteristics. Fair
values are based on observable market transactions, when available. When they are unavailable, fair values are estimated using valuation
models incorporating a range of input assumptions. These assumptions may include: value estimates from third-party brokers reflecting over-
the-counter trading activity; forward-looking discounted cash flow models, taking account of expected customer prepayment rates, using
assumptions that HSBC believes are consistent with those that would be used by market participants in valuing such loans; recent origination
pricing for similar loans; and trading inputs from other market participants including observed primary and secondary trades. From time to time,
we may engage a third-party valuation specialist to measure the fair value of a pool of loans.
The fair value of loans reflects expected credit losses at the balance sheet date and estimates of market participants’ expectations of credit
losses over the life of the loans, and the fair value effect of repricing between origination and the balance sheet date. For credit-impaired loans,
fair value is estimated by discounting the future cash flows over the time period they are expected to be recovered.
Financial investments
The fair values of listed financial investments are determined using bid market prices. The fair values of unlisted financial investments are
determined using valuation techniques that incorporate the prices and future earnings streams of equivalent quoted securities.
Deposits by banks and customer accounts
The fair values of on-demand deposits are approximated by their carrying amount. For deposits with longer-term maturities, fair values are
estimated using discounted cash flows, applying current rates offered for deposits of similar remaining maturities.
Debt securities in issue and subordinated liabilities
Fair values in debt securities in issue and subordinated liabilities are determined using quoted market prices at the balance sheet date where
available, or by reference to quoted market prices for similar instruments.
Repurchase and reverse repurchase agreements – non-trading
Carrying amounts of repurchase and reverse repurchase agreements that are held on a non-trading basis provide approximate fair values. This
is due to the fact that balances are generally short dated.
HSBC Holdings
The methods used by HSBC Holdings to determine fair values of financial instruments for the purposes of measurement and disclosure are
described above.
Fair values of HSBC Holdings’ financial instruments not carried at fair value on the balance sheet
2024
2023
Carrying amount
Fair value1
Carrying amount
Fair value1
$m
$m
$m
$m
Assets at 31 Dec
Loans and advances to HSBC undertakings
37,677
38,359
27,354
27,878
Financial investments – at amortised cost
10,328
10,335
19,558
19,531
Liabilities at 31 Dec
Debt securities in issue
64,320
65,123
65,239
65,172
Subordinated liabilities
23,548
25,911
24,439
26,651
1Fair values (other than Financial investments which are Level 1) were determined using valuation techniques with observable inputs (Level 2).